<?xml version="1.0" encoding="UTF-8"?>
<p>Human monocytic ehrlichiosis (HME) is an emerging zoonosis, which was first described in the United States in 1987, and the first case of HME was documented in 1991 in the United States; the causative agent is 
 <italic>Ehrlichia chaffeensis</italic>, which is an obligate intracellular pathogen affecting monocytes and macrophages [
 <xref ref-type="bibr" rid="B43">43</xref>]. Frequent symptoms of this disease are fever, chills, headache, myalgia, nausea, rash, leukopenia, thrombocytopenia, elevated serum aminotransferase levels, and elevated creatinine levels; the case-fatality rate is approximately 1.9% or higher [
 <xref ref-type="bibr" rid="B43">43</xref>].
</p>
